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Attitudes and attributes of pharmacists in relation to practice change – a scoping review and 1 
discussion 2 
Abstract: 3 
Background: Multiple barriers and facilitators to the uptake of cognitive services in pharmacy practice 4 
have been identified. Pharmacists’ attitudes and attributes have been described as barriers and 5 
facilitators in relation to the uptake of extended pharmacy services, in addition to those of a more 6 
systemic nature.  7 
Objectives: To systematically scope and review the literature describing pharmacists’ attitudes and 8 
attributes in relation to the implementation of cognitive services or role extension and to critically 9 
analyse and discuss their relevance as barriers or facilitators. 10 
Method: A scoping review of the literature on attitudes and attributes of pharmacists in relation to 11 
pharmacy practice was performed, including 47 articles on attitudes and 12 on attributes, forming the 12 
basis for a critical analysis within theoretical frameworks.  13 
Results: Pharmacists’ attitudes towards role extensions and new pharmacy service models are 14 
generally positive and their personal attributes and personality traits appear favourable for roles as 15 
health professionals. Pharmacists perceived a number of barriers to the uptake of extended roles. 16 
Conclusion: Pharmacists’ attributes, including personality traits, and attitudes favour the 17 
implementation of cognitive and patient-focused health care services and should not be regarded as 18 
major barriers to the uptake of extended pharmacy practice roles. Framing their attitudes and 19 
attributes within the theories of planned behaviour and personality trait theories indicates that 20 
individual motivation needs to be underscored by systemic support for pharmacy practice change to 21 
succeed on a wide scale. 22 
Keywords: pharmacist, attitude, attribute, personality trait, cognitive pharmaceutical services, 23 
pharmaceutical care 24 
Introduction: 25 
Pharmacists have had many opportunities to develop their professional role over the last three 26 
decades. By many measures pharmacy as a health profession and a business model has been changing 27 
constantly and with it the practice of individual pharmacists. Like other health professionals 28 
pharmacists have to continuously adapt to changing business and health care models, government 29 
policies and regulations, technology and its application, new diseases and treatments, continuous 30 
changes and updates to treatment and lifestyle guidelines and increased consumer engagement with 31 
healthcare decision-making. In many countries and jurisdictions pharmacists’ scope of practice is 32 
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extending considerably and the supply of medicines role is increasingly moving from the centre of 33 
pharmacists’ practice.1-4  34 
Change and innovation in health professions often relates to the implementation and application of 35 
new technologies or techniques.  In pharmacy more advanced technologies assisting in medication 36 
supply, workflow and business management, the outsourcing and specialisation of tasks like 37 
compounding or preparation of dose administration aids, enables pharmacists to become more 38 
involved in other health care activities. A recent workforce survey of pharmacists in the USA showed 39 
that from 2009 to 2014 pharmacists decreased the time devoted to medication dispensing from 55% to 40 
49% and increased their time providing patient care services from 16% to 21%. Time spent on other 41 
activities did not change significantly, 13% was allocated to business and management, 7% to 42 
education, 4% to research and 6% to other activities. Medication Therapy Management (MTM), 43 
which includes a comprehensive, interactive review of medicines, identifying drug interactions and 44 
gaps in medication use, was offered by 60% of community pharmacies. Immunisation services had 45 
been implemented by 53%, and 52% reported monitoring and adjusting of medication therapy to 46 
attain desired outcomes.4  47 
A number of barriers and facilitators for change in pharmacy practice have been identified, for 48 
example competence and confidence of pharmacists or a lack thereof and public or organisational 49 
support, with a variety of factors exerting influence on the adoption rate of new practice models and 50 
extension of pharmacist roles as health care providers.5-10 Many of these factors, such as workplace 51 
design, work flow and regulatory requirements, originate from within the system and external 52 
environment pharmacists practice in.9, 11, 12, 13 Few studies investigated the interventions or actual 53 
process of accomplishing changes in pharmacist behaviour and how these were promoted or 54 
supported.14 Some barriers to change have been attributed to pharmacists as individuals, with 55 
pharmacists described as reluctant to change their practice to implement novel service models, which 56 
involve more patient contact and clinical responsibility than the supply of medicines.15 57 
While many pharmacists are extending their professional roles a significant number seems hesitant in 58 
providing novel services and accepting new responsibilities in patient care while the evidence for their 59 
outcome benefits to patients is still emerging.16, 17 Slow uptake of roles as prescribers, reluctance to 60 
take responsibility for outcomes in patient care and closer involvement with patients has been related 61 
to pharmacists’ personal attributes and personality traits as well as to their attitudes and beliefs.15 The 62 
extent to which pharmacists’ individual or personal attributes and attitudes are inhibitors to extending 63 
their roles and whether these are innate or possibly acquired throughout their training, 64 
professionalisation and professional practice warrants consideration. Understanding how attitudes and 65 
attributes or external and systemic factors influence the uptake of wide spread practice change will 66 
potentially guide future implementation strategies for changes to pharmacy practice. 67 
This paper provides a critical analysis of recent empirical research examining pharmacists’ attitudes 68 
and personal attributes and whether they constitute barriers or facilitators to practice change. In this 69 
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context attitude can be understood as the degree to which a pharmacist has formed a favourable or 70 
unfavourable evaluation or appraisal of a specific role or cognitive service and attribute as a 71 
psychological characteristic of an individual.18 The format of a scoping review was chosen as it allows 72 
for mapping a broad range of evidence and the summation of research findings generated by studies 73 
of potentially widely varying designs. It lends itself to providing a narrative overview of a broadly 74 
defined topic and the potential identification of future reseach opportunites.19 75 
 76 
Methodology 77 
A preliminary screen of the literature identified the body of published research into attitudes and 78 
attributes of pharmacists as heterogeneous and mainly qualitative in nature.  Thus a scoping review 79 
was chosen as the method of summarising and disseminating the findings of this wide range of 80 
research.19 A scoping review was also deemed a suitable methodology to accommodate expected 81 
difficulties in determining the inclusion or exclusion of studies due to the broad terms of reference of 82 
the review and the not always unambiguous use of terms of interest, e.g. ‘cognitive services’, in the 83 
literature. 84 
 A literature search of MEDLINE, CINAHL via EBSCOhost and PsycINFO databases was performed 85 
with the search terms of pharmaceutical services or care, community pharmacy services, pharmacy or 86 
pharmacies, pharmacist* as major subject headings or key words, combining results with a search for 87 
attribute* and attitude* as text words. The search process was supported by a specialist librarian. The 88 
exact final search strategies are provided in appendix 1. Searches were restricted to publications 89 
written in English and published from 2000-2015. Titles and abstracts were reviewed to identify 90 
studies which described the attributes and attitudes of pharmacists in relation to the implementation of 91 
what would be regarded as cognitive or extended pharmacy services or practice change.20  92 
Studies were included for review and discussion when they reported on empirical research into the 93 
attitudes or personal attributes of pharmacists and pharmacy students in relation to pharmacy services 94 
which were described as novel, extended or advanced in the respective publication. For inclusion the 95 
cognitive pharmacy services had to be well defined in the article, e.g. supplementary or independent 96 
prescribing, or been clearly defined in the pharmacy literature, e.g. medication therapy management, 97 
pharmaceutical care. In addition studies providing detailed descriptors of the investigated pharmacy 98 
service, with the service entailing a structured, individualised approach to patient care, were included. 99 
Studies into pharmacists’ personal attributes had to use a validated psychometric assessment tool. 100 
Inclusion was limited to research conducted within health care systems with similar structures and 101 
governance. Studies from North America, Europe, Australia or New Zealand were chosen to attain an 102 
approximation of similarity in health care systems and regulation and practice of pharmacy, aimed at 103 
limiting heterogeneity and increasing the potential of legitimately generalising the findings.  104 
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Studies were excluded from the review when pharmacists’ attitudes to or attributes in relation to 105 
broadly defined healthcare or unspecified support services were examined, e.g. general health 106 
promotion, as well as some public health services, e.g. disease or addiction screening.  107 
Reference lists of included articles and relevant review articles were screened for additional studies.  108 
Fig. 1. Flow chart for selecting literature for inclusion in scoping review. 109 
[Insert figure 1 here] 110 
Screening of the literature made obvious that research into attributes of pharmacists focused on 111 
personality traits.  In order to ascertain whether pharmacists exhibit similar or different personality 112 
trait profiles to other health professionals, whose scope of practice is regarded as variable and 113 
extending, the search was widened to permit comparisons of traits. A separate search was performed 114 
to identify research conducted into personality traits of pharmacists and pharmacy students as well as 115 
other health care professionals world-wide. MEDLINE, CINAHL and PsycINFO were searched for 116 
the terms personality, pharmacist*, medical or medicine, nurs* and health professional* within the 117 
date range of 2000-2015. Additional titles and abstracts which indicated investigation of personality 118 
traits in relation to the provision of pharmacy or healthcare services were flagged for full-text retrieval 119 
as well as studies which enabled comparison of personality traits with other health professionals. This 120 
iterative process yielded another 3 articles on pharmacists’ personality traits to the review. In total, 121 
screening, article review, iterative and reference searches resulted in the final inclusion of 47 articles 122 
on pharmacists’ attitudes and 12 on attributes. 123 
Eligible studies were assessed for participant enrolment, pharmacy service or practice model studied, 124 
methodology and major empirical findings.  125 
A knowledge synthesis achieved by the scoping review forms the basis of a critical analysis and 126 
discussion of the relevance of attributes and attitudes of individual pharmacists or pharmacy students 127 
in the development or implementation of practice change and new health care service models in 128 
pharmacy.21 Theory of Planned Behaviour (TPB) and personality trait theories were employed as 129 
theoretical frameworks to inform the discussion of results. TPB was chosen a priori as a framework to 130 
investigate pharmacists’ attitudes to changing practice as it links behaviour change to attitudes and 131 
external factors potentially relevant to successful practice change. TPB posits that once beliefs and 132 
attitudes about a certain behaviour are positive, the likelihood of developing an intention to exert the 133 
behaviour increases, with strength of intention consequently predicting the execution of behaviour.18 134 
Personality trait theory, which contends that human behaviour is strongly influenced by attitudes and 135 
beliefs generated through habitual patterns of thought and emotions, was integrated once it became 136 
clear that research on pharmacists’ personal attributes focused on their personality traits. 137 
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 138 
Results 139 
Pharmacists’ attitudes towards cognitive services and practice change 140 
A significant number of qualitative or mixed methods studies have evaluated pharmacists’ attitudes 141 
towards cognitive services in pharmacy practice and patient care, using mainly surveys, focus groups 142 
and semi-structured interviews. Research describing attitudes and attributes mainly included 143 
community pharmacists but also pharmacists working in other health care settings, e.g. primary care 144 
or hospitals. Appendix 2 tabulates studies which report on pharmacists’ attitudes towards the 145 
implementation or delivery of cognitive and extended pharmacy services. Attitudes towards MTM,22-146 
26
 pharmaceutical care 27-31 and medication utilisation reviews 32-36 have been reported. Similarly, 147 
attitudes and intentions to participate in or implement immunisation programs in community 148 
pharmacies 12,  37-40 and the provision of patient-focused services by pharmacists,8, 41 for example 149 
adherence support 42-44 and chronic disease management 45-47 or other support services,48, 49 have been 150 
studied. Pharmacist prescribing as either supplementary or independent prescribers has been the focus 151 
of attitude research,2, 3, 50-61 in addition to pharmacists’ integration into health care teams, e.g. primary 152 
care practices.62-64 Some of these studies also described positive intentions to implement services and 153 
elucidated on barriers and facilitators.2,22,27,51,64 154 
Studies investigating pharmacists’ general attitudes towards extended practice roles concluded that 155 
pharmacists’ attitudes and intentions for change were mostly positive, despite perceived barriers in 156 
their organisational environment.48,65 Pharmacists expressed necessity, willingness or enthusiasm to 157 
extend their roles, though often perceived their external environment creating obstacles to do so.61 158 
Positive attitudes and intentions to implementing change or taking up specific new roles were 159 
represented in most of the studies looking at immunisation,12, 38, 39 pharmacist prescribing,51-53, 57, 58, 60, 160 
61
 patient-focused support services,8, 42-44, 49 medication management or review services 22, 23, 27-29, 33, 34 161 
and collaboration with other health professions.63 Positive attitudes were expressed in terms of 162 
perceived benefits for patients,34, 36, 40, 44, 56, 58, 65 for example the prevention of adverse drug events,26 163 
improved access to and continuity of care 2, 51, 55, 61 or improved adherence to medicines.55 Pharmacists 164 
had positive opinions on how role extensions or novel services would benefit their individual practice 165 
or the pharmacy profession. Advancement of the profession and an increase in professional standing 166 
and role enhancement formed parts of positive attitudes.25, 30, 34, 38, 54, 56, 60, 65 Pharmacists perceived a 167 
potential or actually experienced an increase in role satisfaction.40, 43, 44, 52, 57, 61 They also expressed 168 
recognition of how roles beyond medication supply, such as conducting formalised, interactive 169 
medication reviews, would increase the acceptance of pharmacists by other health professionals and 170 
facilitate the integration into health care teams.36, 55 171 
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Pharmacy students also expressed positive beliefs and attitudes towards future roles in clinical and 172 
patient care and motivation to extend their practice. At times these were independent of their level of 173 
skill and competence.40 They also showed intention to implement immunisation programs at their 174 
future place of work, irrespective of the measure of control they may have to do so in practice.66 175 
When pharmacists’ attitudes and beliefs were correlated to concerns about the implementation of 176 
cognitive services or uptake of an extended role barriers and facilitators which potentially reside with 177 
the individual were identified and described. The need for additional training and competence was 178 
frequently mentioned, particularly in relation to prescribing with a focus on training in diagnosis as 179 
well as assessment and monitoring, and immunisation. 27, 28, 37, 48, 51-53, 58, 65 In some settings 180 
pharmacists perceived a lack of mandate from the public or other health professionals 8, 32 or the need 181 
for more collaborative relationships with other health professionals, particularly physicians.3, 36, 44 The 182 
most frequently cited barriers to the uptake of any new service were a lack of time to provide patient-183 
focused services in a busy pharmacy or retail environment and an unsuitable work environment or 184 
work flow, clearly pointing to organisational and environmental issues.12, 22, 23, 27, 28, 34, 37, 39, 41-43, 53, 60 185 
Pharmacists’ attributes in relation to cognitive services and practice change 186 
Empirical research investigating pharmacists’ personal attributes in relation to practice change almost 187 
exclusively explored their ‘Big Five’ personality traits.67-78 Appendix 3 provides an overview of the 188 
included studies which used a validated psychometric instrument measuring personal attributes and 189 
traits as well as summarising their key findings . 190 
Personal attributes and personality traits are believed to influence the formation of beliefs and 191 
attitudes.79 They are understood as relatively enduring dispositions, predisposing a person to certain 192 
patterns of thoughts, feelings and influencing how they interact with their environment 79, 80 and are 193 
regarded as reasonably stable across, particularly later, adulthood.81, 82 In the 1990s consensus 194 
emerged that personality traits can be organised within five broad factors, the ‘Big Five’, namely 195 
Extraversion, Neuroticism, Openness to Experience/Intellect, Agreeableness, and Conscientiousness. 196 
These five traits, deriving from a number of underlying facets and developed into the Five Factor 197 
Model (FFM), are thought to explain much of the variance in human behaviour.79 The validity and 198 
utility of the FFM is not without contention. The reduction of variance in complex behaviour to a few 199 
global factors appears simplistic within the socio-cognitive model of human behaviour, where theories 200 
around self-efficacy, self-regulation or goal orientation are offering cogent explanations.83, 84 A 201 
number of instruments to measure Big Five personality traits have been developed. In common use 202 
are the NEO Five-Factor Inventory (NEO-FFI), the NEO Personality Inventory-Revised (NEO-PI-R) 203 
and the Big Five Inventory (BFI).85-87  204 
Studies involving pharmacists mainly employed the BFI as an assessment tool, often correlating 205 
results to performance of patient care services like MTM, immunisation or prescribing.67-72 206 
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Participating pharmacists rated higher scores for the FFM traits of conscientiousness and emotional 207 
stability and at least as high or higher for agreeableness than the relevant population average.88 208 
Pharmacists expressed varying degrees of extraversion but consistently a lesser degree of openness to 209 
new experiences than the general population. A comparison of the results of these studies with the 210 
limited number of small studies of other health professionals or students using the BFI shows that 211 
participants in the vast majority similarly reported higher degrees of agreeableness, conscientiousness, 212 
emotional stability, varying degrees of extraversion and a lower than average degree of openness to 213 
new experiences compared to population means. Physiotherapists, surgeons, physicians, other doctors, 214 
medical and psychology students all exhibited for example lower than average scores of openness to 215 
experience, mirroring findings from the pharmacist studies.89-93 The only professional group reaching 216 
the population mean score for this trait was a small group of occupational therapists.91  217 
Research applying the two other commonly used FFM inventories, the NEO-PI-R or NEO-FFI 218 
instruments, finds slightly different trait profiles for health professionals. The only study applying the 219 
NEO-FFI to pharmacists was conducted in Thailand, rating them high on agreeableness, 220 
conscientiousness, average openness, average to low extraversion and low on neuroticism.78 The use 221 
of the NEO-PI-R found mixed results with small groups of pharmacy students in Taiwan and 222 
pharmacists in South Africa, which are not easily compared to population means.76, 77 Most studies 223 
have been conducted within the medical profession and correlated personality traits for example to job 224 
satisfaction,94 preference for urban or rural practice 95 and patient satisfaction.96 These as well as 225 
studies involving medical students confirmed the trend of higher than average conscientiousness, 226 
agreeableness and emotional stability but not the findings from research using the BFI of low 227 
openness to experience by practicing or aspiring medical professionals. Studies employing the NEO-228 
PI-R and NEO-FFI showed doctors and medical students scoring average to high for openness when 229 
reporting the raw or adjusted scores for the personality measures compared to population averages.97-230 
103
 Similar results were obtained in studies involving nurses and nursing students.104-106  231 
Cordina et al. conducted a number of studies using the Gordon Personal Profile Inventory (GPP-I) 232 
with Maltese pharmacists and pharmacy students, investigating personal attributes in relation to 233 
practice.73-75 Practicing pharmacists showed the highest mean score for responsibility, followed by 234 
vigour, cautiousness and original thinking.73 First year pharmacy students marked their highest scores 235 
in original thinking, personal relationships, vigour, responsibility, and low scores for self-esteem, 236 
emotional stability and ascendency.74 In a follow up study after 4 years pharmacy students seemed to 237 
have consolidated their traits on the GPP-I but became more cautious and responsible.75  238 
 239 
Discussion 240 
Attitudes 241 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Studies of pharmacists’ attitudes towards and opinions about cognitive services and new roles indicate 242 
that they formed mainly favourable evaluations, perceiving many benefits to patients, themselves as 243 
individuals and the profession. Although pharmacists expressed positive attitudes the actual 244 
implementation and provision of cognitive services is often perceived as lacking in practice.15 Even 245 
when individuals have taken appropriate steps to facilitate the transition from intended to actual new 246 
behaviours the rate of practice change can be limited.34, 50, 107 Theory of Planned Behaviour (TPB) 247 
offers a useful framework when looking for possible explanations for the gap between pharmacists’ 248 
positive beliefs and attitudes and the actual or perceived lack of practice change behaviour.18 PB 249 
explains up to 27% of the variance in certain behaviours and up to 39% of the variance in intentions to 250 
action a behaviour, with effect size varying according to behaviour type.108, 109 Positive beliefs and 251 
attitudes about a certain behaviour increase the likelihood of developing an intention to exert the 252 
behaviour.18 Other factors influencing intention are subjective norms (SN), which provide permission 253 
or approval, social pressure or a mandate for pharmacists to perform certain professional roles. 254 
Pharmacists also need to feel they have a degree of control over the performance of their intended 255 
behaviours and actions, i.e. that they have the necessary means, ability, skills and competence. This 256 
perceived behavioural control (PBC) is another significant predictor for intention and subsequent 257 
behaviour.18 For TPB to apply a degree of actual behavioural control needs to be present, which may 258 
not be the case where pharmacists are not the designated decision-makers in their practice setting. 259 
Due to often working within a regulated or structured environment, systemic and organisational 260 
structures may not permit a motivated, well intended and competent individual to start a new 261 
behaviour without organisational or regulatory permission, limiting actual control, as experienced by 262 
pharmacists who obtained prescribing authorisation in the UK.2, 50  263 
Within this theoretical framework attitudes are generally found to be the strongest predictor variable 264 
for intention, followed by PBC and SN, with intention often regarded a proxy measure for actual 265 
behaviour. 24, 108, 110 It seems that pharmacists and particularly pharmacy students’ behavioural beliefs 266 
and attitudes form favourable antecedents to developing intentions to practice in new or extended care 267 
roles.111 Studies reporting that the presence of positive attitudes to providing MTM or pharmaceutical 268 
care correlates positively to a higher likelihood of providing these services illustrate these theoretical 269 
aspects.25,  67 270 
Subjective norms can partly support or hinder pharmacists in extending professional roles and scope 271 
of practice. Professional organisations and regulations, academia, existing professional training and 272 
consumer or health professional expectations all create norms which may generate incentives or 273 
disincentives for pharmacists to extend their skills and participate more actively in health care. Some 274 
pharmacy practice studies confirm that SN can be a reliable and strong predictor of intention to 275 
participate or implement a novel pharmacy service.24, 113, 114 This finding seems to apply particularly 276 
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when actual and perceived control over the behaviour is high, e.g. with the use of drug monitoring 277 
databases or adverse drug event reporting.115-117   278 
A pervasive factor influencing SN negatively seems to be a lack of physician support, absence of 279 
established networks and clear acceptance by other health professionals. Physicians often express 280 
uncertainty or ambiguity towards pharmacists’ clinical involvement, questioning their legitimacy and 281 
competence in taking up extended roles.24, 36, 118-122 In order to strengthen SN for pharmacists and ease 282 
the transition from intention to action in many practice areas relationships and networks need to be 283 
established. This seems particularly important where there is an overlap in roles and responsibilities 284 
with other health professions, for example prescribing and immunisation. Many pharmacists have 285 
negotiated these professional boundaries with success.62, 63 They found that trust and collaboration 286 
between health professions removes barriers to positive recognition of pharmacy services and the 287 
individual providing them,123-126 and prefer integration into primary and secondary care.127 288 
Professional relationships can be encouraged during the training of health professional students, e.g. 289 
by integrating interprofessional education or practice placements with other health professions into 290 
graduate degree programs. These will establish early role clarity, a mutual understanding of 291 
practitioners’ skills and abilities and facilitate the negotiation of professional boundaries. Enhancing 292 
pharmacists’ interprofessional communication skills alongside their clinical skills will encourage and 293 
support the establishment of collaboration and trust at an individual practitioner level. At the same 294 
time collaboration has to be negotiated between respective professional organisations, who usually 295 
drive the extension of pharmacists’ scope of practice but then seem to leave the negotiation of 296 
professional frontiers to practitioners at the coal face.128 297 
The increasing commercialisation of pharmacy may create another substantial hurdle for pharmacists 298 
due to the actual or perceived conflict of business interests with the provision of health care. The 299 
negative impact this may have on relationships with other health professions and consumers has been 300 
identified in a number of studies on role extension and will potentially influence SN.35, 47, 126, 129, 130 301 
Relationships are at the core of healthcare and central to shaping the public’s expectations of 302 
pharmacists’ role as healthcare providers. Attention to the psychosocial dimensions of their 303 
interactions with consumers in place of a more transactional approach to the practice of pharmacy will 304 
strengthen relationships.1 This will enable pharmacists to assist people in changing behaviours which 305 
are detrimental to their well-being, extending existing patient care skills to supporting people to take 306 
responsibility for all aspects of their health and heath care. Similarly to improving interprofessional 307 
training of pharmacy students involving them in early person contact and participation in patient-308 
focused and cognitive services can facilitate the development of an identity as carer. This would also 309 
broaden the understanding of those who are attracted to pharmacy by its connotations of a science 310 
based profession. Many pharmacists have already seized the opportunities to introduce patient-311 
focused health services, portraying their role and image as health carers more explicitly, without 312 
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having to rely on funding or regulatory approval. Pharmacists and pharmacies offer unfunded and 313 
funded services which are supporting the goals of primary health care in disease prevention and 314 
chronic disease management, e.g. in promoting smoking cessation and lifestyle changes or asthma 315 
management.14 Ensuring pharmacy services are delivered to a high standard and technical quality will 316 
raise consumer and health professional expectations, reinforcing SN. An improvement of their 317 
functional quality is likely to strengthen the perception of pharmacists as carers and clinicians. For 318 
pharmacists to consistently succeed in their obligations and ambitions actual and perceived 319 
behavioural control will be necessary.  320 
PBC is another strong predictor of positive intentions in pharmacy practice studies employing TPB as 321 
a framework, although not as strong as described in literature on health behaviour,112, 114 and has been 322 
found a predictor for the likelihood of providing pharmaceutical care.69 Pharmacists with positive 323 
attitudes often cite barriers in relation to workload and work environment which as well as 324 
competence, skill and need for training all link to PBC. While necessary competence and skill for 325 
extended or novel roles can be gained by individuals either during their graduate training or 326 
continuing professional development, barriers in their work environment are not as easily removed by 327 
the majority of pharmacists. Figure 2 summarises how TPB frames pharmacists’ attitudes, facilitators 328 
and barriers to role extension as described in the literature. 329 
Pharmacy business models have changed over the last decades but changes in physical environments, 330 
e.g. in community pharmacies, are only slowly creating conditions which are conducive to conducting 331 
patient-focused, clinical consultations.7 This slow transformation potentially feeds the public’s 332 
perception of pharmacies operating mainly as a business rather than a healthcare centre. Research into 333 
how to optimise work flow, work place design and staffing levels to facilitate regular performance of 334 
relationship-based, individualised services would assist pharmacy as a profession and pharmacists as 335 
individuals in extending their roles into many areas of healthcare. Addressing environmental and 336 
organisational factors which create difficulties for motivated pharmacists to fully participate in 337 
cognitive service provision and strengthening their PBC should increase pharmacists’ chances to 338 
succeed in taking on new roles as discussed, for example, by Farris et al.131  339 
Figure 2. Attitudes, facilitators and barriers described by pharmacists within the Theory of Planned 340 
Behaviour 341 
[Insert figure 2 here] 342 
Personal Attributes 343 
Research into pharmacists’ attributes in relation to cognitive pharmacy services focused mainly on 344 
their personality traits. When measured with the BFI, a FFM instrument, pharmacists and other health 345 
professionals in comparison to the population average rated scores which were higher for the traits of 346 
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conscientiousness and emotional stability, average to higher for agreeableness, lower to higher for 347 
extraversion and lower for openness to experience.67-72, 89-93 Within the FFM higher degrees of 348 
conscientiousness have been established as predictors for job and academic performance, with 349 
extraversion seemingly relevant for success in sales and management. When jobs rely on 350 
interpersonal interaction, like team work, agreeableness and emotional stability seem to be more 351 
important for success, but other traits have not been proven to be reliable predictors of people’s 352 
performance or behaviour on the job.132-134 Although correlations were not established with all FFM 353 
instruments, higher degrees of extraversion and openness are often linked to people being less 354 
conventional, and openness in particular to creativity, innovativeness and divergent thinking.135, 136 355 
These findings may lead to conclusions that pharmacists’ personality traits, particularly a low degree 356 
of openness to new experiences, may constitute barriers to the implementation of innovative practice 357 
change. On the other hand Rosenthal et al., studying early adopters obtaining additional prescribing 358 
authorisation in Canada, found they rated similarly in their BFI measured personality profile as 359 
pharmacists in their previous studies. Even these early adopter pharmacists showed a lower rating 360 
than the population mean for the trait of openness with the BFI and thus no definite link of this trait to 361 
an early interest in an extended scope of practice.70 A recent meta-analysis investigating the degree of 362 
openness in relation to adaptive performance also confirms no significant correlation.137  363 
Direct comparisons of studies with health professional participants using varying ‘Big Five’ 364 
instruments are difficult as definitions of traits are slightly but significantly different, emphasising 365 
distinctive facets underlying each trait. For example the NEO-FFI defines extraversion with an 366 
emphasis on positive emotions and warmth, having less focus on assertiveness compared to the BFI.87 367 
There are divergent reports on how much the BFI, the NEO-PI-R and NEO-FFI (a shorter version 368 
derived from the NEO-PI-R) correlate and converge for all five traits.138, 139 Convergence between the 369 
BFI and NEO-PI-R for some traits (i.e. agreeableness and openness) was poor in a large study with 370 
participants from 56 nations.138 The BFI and NEO-FFI have also shown only moderate convergence 371 
for the trait of openness. A direct comparison of scores between studies using different instruments is 372 
thus inappropriate. The best approximation when comparing different studies would be using 373 
conclusions about group differences to population means established with the respective instrument.87 374 
Research applying the NEO-PI-R or NEO-FFI instruments with pharmacists, other health 375 
professionals and students often found an average to higher than average degree of openness, while 376 
confirming trends for the other traits.77, 78, 97-103 This divergence of results obtained from studies using 377 
the BFI may be associated with the way the BFI measures openness, possibly not providing a good 378 
model fit for people who become or are health professionals. The BFI measures openness by an 379 
underlying facet profile which asks three out of ten questions around interests in artistic and aesthetic 380 
experiences.87 These may have poor validity in those whose curiosity and inventiveness is potentially 381 
focused on scientific and technological innovations and applications. The BFI may consistently 382 
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underestimate health professionals’ openness to experience compared to the other two commonly 383 
used FFM instruments.136 In the absence of additional pharmacist studies using the instruments more 384 
frequently employed in other health professional research it remains unclear whether pharmacists in 385 
western societies are the only health profession which would consistently maintain lower scores for 386 
the trait of openness compared to population averages and other health professionals if their 387 
personality was measured by the use of the NEO-FFI or NEO-PI-R.  388 
An argument against the probability of this scenario can be found in the studies conducted by Cordina 389 
et al., using the Gordon Personal Profile Inventory (GPP-I).73-75 Results obtained with the GPP-I are 390 
not directly comparable with FFM instruments as they provide information on personality based 391 
competencies, structured into four domains of interests, work style, preferences and work values. 392 
Pharmacy students showed high scores in original thinking, which seemed to decrease slightly 393 
between the first and fifth year of their degree. High scores for original thinking are deemed to signify 394 
people who are intellectually curious, creative innovators and like to work on difficult problems, 395 
which seemingly correlates well to openness to new experience within the FFM.140 These findings, 396 
though limited in their singularity, support the argument that pharmacists’ low openness may well be 397 
an artefact of the use of the BFI as a measurement instrument when considering the studies on 398 
pharmacists’ personalities which have shaped understanding until now.  399 
Cordina et al. studies hint at pharmacists exhibiting a degree of cautiousness and a dislike of 400 
uncertainty,73-75 which has also been proposed by others,141, 142 but they do raise the question whether 401 
pharmacy students commence their studies with these attributes or whether they develop them 402 
throughout their training and professionalisation. The ability to practice with accuracy and correctness 403 
is regarded as probably the most important professional attribute of a pharmacist, with potential 404 
serious consequences for errors in what for many is still a core activity, dispensing.130 A need for 405 
certainty and precision is predictable when demands from the profession and public permit little 406 
tolerance for errors but is not easily reconciled with uncertainty in clinical decision making in 407 
extended practice roles.  Training and professionalisation may well encourage the development of 408 
these attributes.142-145 Currently it remains uncertain to what degree pharmacists’ cautiousness and 409 
discomfort with uncertainty are innate personal attributes rather than products of training, professional 410 
socialisation and norms. Further research into how pharmacists professionalise in comparison to other 411 
health professionals, who seem to be more at ease when making decisions under uncertainty but 412 
exhibit similar personality traits, may shed light onto how and when pharmacy students or 413 
pharmacists acquire these attributes.  414 
In summary, pharmacists’ attitudes and intentions towards role extensions and potential practice 415 
change appear generally positive. Empirical findings published within the last 15 years show that it is 416 
unlikely that pharmacists’ personality traits or personal attributes create major barriers to extensions 417 
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of current roles into patient-focused services. They indicate that people who are or become 418 
pharmacists should be well suited to a wide range of health professional roles. Pharmacists display 419 
similar personality trait patterns to other health professionals and could be expected to exhibit 420 
behaviours which are conducive for roles in health care. Like in other health professions, pharmacists 421 
with certain personality profiles may be drawn to and succeed in particular roles within their 422 
profession.74, 76 Surgeons or psychiatrists on average tend to differ slightly in their personality from 423 
their peers but a correlation between a certain personality profile and high performance in these roles 424 
has not been established.90, 146, 147  425 
Younger generations of pharmacists in particular seem to possess attributes and attitudes favourable to 426 
adapting to future practice changes and patient-focused health care.56, 75, 142 They often report feeling 427 
let down though by the educational system, realities of pharmacy practice and professional 428 
organisations when trying to realise the potential they perceive for their chosen profession.144, 148, 149 429 
Pharmacy training programs can provide assistance in ensuring students complete their degree fit for 430 
extended practice. Strengthening SN by increasing collaboration with other health professions and 431 
consumers, with the aim of integrating pharmacy universally into team based care, will over time 432 
reduce potential scope of practice gaps when transitioning from student to health professional. When 433 
pharmacists perceive customers, patients and other health professionals giving them a mandate or 434 
expecting pharmacists to provide cognitive services in addition to the more traditional roles of 435 
medication supply cognitive dissonance between positive attitudes and SN will weaken. In addition 436 
optimising work flow and practice design to advance patient centred consultations may also mitigate a 437 
potential lack of actual control for those with good intentions which are not translated into planned 438 
behaviour and increase perceived behavioural control in changing practice.2, 50, 131 At the same time 439 
acceptance that taking on new roles may seem more important to professional organisations or 440 
business owners concerned with pharmacy’s obsolescence than to individual, mature practitioners 441 
who feel competent and content within their current scope of practice could direct future research into 442 
addressing systemic issues which may impede practice change in pharmacy.150 443 
There are a number of limitations to this review. Searches were restricted to the English language and 444 
a defined geographical area, it is acknowledged that a small number of potentially relevant studies has 445 
been conducted in other areas, although within dissimilar health care systems. As cognitive, advanced 446 
or extended services in pharmacy practice are not always clearly defined in the research literature 447 
potentially relevant articles may have been missed, although the broad search strategies were aimed at 448 
keeping a wide focus. Care was taken that the exact nature of the pharmacy service under discussion 449 
was described to pharmacist participants in the included studies, but it was impossible to assess the 450 
degree of their understanding and awareness to ensure they were able to form well-informed beliefs 451 
and attitudes.  452 
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 Concluding remarks 453 
This review of literature that explores pharmacists’ beliefs, attitudes, intentions and attributes 454 
concludes that people who are or are becoming pharmacists are well suited for a career as health 455 
professionals. Research demonstrates their positive attitudes and intentions towards the extension of 456 
their scope of practice, uptake of cognitive and patient-focused pharmacy service models and greater 457 
involvement in health care.  458 
While individual pharmacists who chose to extend their scope of practice and ensure they are skilled 459 
and competent to do so can take more responsibility in initiating and building relationships with other 460 
health professionals and they will need support in strengthening subjective norms through the 461 
increasing acceptance of new pharmacist roles by the people they work with or serve. In preference to 462 
tasking individuals with closing any knowledge, attitude, practice gaps systemic issues in pharmacy 463 
practice and service delivery need to be addressed. These may be complex and difficult, but 464 
continuing to resolve them will ease the efforts of motivated pharmacists to practice to the maximum 465 
scope of their ability and competence. Pharmacists seem to exhibit attitudes and attributes which 466 
favour their involvement in a wide range of health care services and adoption of a practice philosophy 467 
of direct patient care but ongoing systemic change is required to facilitate wide-spread extensions of 468 
pharmacists’ scope of practice. 469 
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Appendix 1. Search strategies 827 
 828 
 829 
 830 
 831 
  832 
MEDLINE ((MH "Pharmaceutical Services") OR (MH "Community Pharmacy Services") OR (pharmacies OR pharmacy OR 
pharmacist*)) AND (attribute* OR attitude*) 
CINAHL ("pharmaceutical care" OR "community pharmacy" OR pharmacist* OR pharmacy OR pharmacies) AND (attribute* OR 
attitude*) 
PsycINFO (“pharmaceutical care” OR “community pharmacy” OR pharmacist* OR pharmacy OR pharmacies) AND (attribute* OR 
attitude*) 
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Appendix 2. Overview of studies reporting on pharmacists’ attitudes in relation to cognitive service implementation  833 
Author(s) / 
Year 
Study objective Participants / 
Location 
Pharmacy Service / 
Research Method 
Major findings 
 Medication Therapy Management (MTM) 
Blake et al.22 To assess pharmacists’ 
perception of educational and 
training needs necessary to 
implement MTMS. 
203/503 community 
pharmacy, 
pharmacists in 
charge, USA 
MTM /  
Survey 
Respondents felt comfortable in providing 
MTMS and had a favourable view of the 
value of these services to patients. 
Herbert et al.24 To predict the behavioural 
intention of pharmacists to 
provide MTM. 
203/500 community 
pharmacists, USA 
MTM / 
Survey 
Pharmacists showed generally positive intent 
to provide MTMS. 
Law et al.23 To explore pharmacists’ 
perceived preparedness, 
willingness, and challenges 
toward providing MTM 
services. 
143 community 
pharmacist, USA 
MTM /  
Survey 
Community independent pharmacists reported 
being ready, willing, and able to provide 
MTM services. A lack of time, billing 
arrangements and reimbursement were named 
as challenges. 
MacIntosh et 
al.26 
To evaluate differences in 
community pharmacy 
managers’ attitudes towards 
MTM based in relation to use 
of Mirixa. 
200 community 
pharmacy managers, 
USA 
MTM /  
Survey 
Majority showed positive attitude towards 
pharmacists providing MTM and its value to 
patients, but stated difficulties finding time 
for MTM or setting aside time for one-to-one 
consultations during business hours. 
Shah and 
Chawla 25 
To investigate pharmacists’ 
attitudes, efforts, interest, and 
challenges in providing MTM. 
93/123 community 
pharmacists, USA 
MTM /  
Survey 
Pharmacists had positive attitudes toward 
provision of MTM, regarding it as an 
opportunity to engage in patient care, and 
were very interested in providing some MTM 
services.  
 Medication (Utilisation) Review 
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Bradley et al.36 To explore and identify the key 
determinants influencing the 
uptake of medicines use 
reviews. 
Primary care 
organisations, 
including community 
pharmacists, UK 
MUR 
commissioning and 
provision / 
Questionnaire & 
interviews, MUR 
data 
Stakeholders believed in the potential for 
MURs to contribute to professional 
integration and patient care. 
 
Bryant et al.32 To explore attitudinal factors 
that prevent increased 
participation of community 
pharmacists in medication 
reviews. 
20 Pharmacists, NZ Medication review 
(GP collaborative) / 
Semi-structured 
interviews 
The themes that emerged from the interviews 
questioned whether provision of clinical 
medication reviews was mandated, had 
legitimacy, was effective, and the adequacy of 
the pharmacist to provide the service. 
Harding and 
Wilcock 33 
To explore existing mechanism 
to ensure quality assurance of 
medicine use reviews. 
50 Community 
pharmacists, UK 
MUR /  
Survey 
Community pharmacists generally had a 
positive attitude towards MURs but think 
special skills are needed to perform MUR. 
Latif and 
Broadman 34 
To explore community 
pharmacists’ attitudes towards 
MUR. 
167/600 community 
pharmacists, Norway 
MUR /  
Survey 
Pharmacists were positive about MUR 
viewing it as beneficial to both pharmacists 
(use of professional skills) and patients 
(improve medicines use). 
McDonald et 
al.35 
To evaluate attitudes towards 
new contracts including MUR 
49 community 
pharmacists, UK 
MUR /  
Interviews 
 
Most pharmacists welcomed the new contract 
including MUR to encourage a move away 
from dispensing. But all pharmacists also 
described their working environment as very 
busy and driven to a large extent by the need 
to maintain dispensing volumes. 
 Pharmaceutical Care 
Amsler et al. 31 To evaluate pharmacists’ 
beliefs about pharmaceutical 
care. 
11 community 
pharmacists, USA 
Pharmaceutical care 
/  
Focus groups 
Pharmacists willing to provide 
pharmaceutical care. 
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Cates et al.29 To explore attitudes of 
pharmacists toward mental 
illness and provision of 
pharmaceutical care to mentally 
ill patients. 
187 community 
pharmacists, USA 
Pharmaceutical care 
/ Survey 
Pharmacists showed positive attitude towards 
providing PC, expressing confidence and 
interest. 
Dunlop and 
Shaw 27 
To determine attitudes to the 
concept of pharmaceutical care. 
 
 377/490  community 
pharmacists, NZ 
Pharmaceutical care 
/ 
Survey 
More than 50% support the concept of PC and 
see the future of pharmacy in professional 
services other than dispensing. Barriers 
identified were lack of time, remuneration, 
adequate skills. 
Liekens et al.28 To evaluate pharmacists’ 
attitudes, current practice, 
perceived barriers and training 
needs concerning 
pharmaceutical care for people 
with depression. 
149/181 community 
pharmacists, 
Belgium 
Pharmaceutical care 
/ Survey 
Pharmacists’ attitude toward their role in 
depression care can be considered positive. 
No difference in attitude to providing PC for 
people with depression or physical illness 
Montgomery et 
al.30 
To explore perceptions of 
pharmaceutical care. 
5 community 
pharmacists, Sweden 
Pharmaceutical 
care/  
Focus groups 
Positive perceptions of PC by pharmacists, 
regarded as professionally rewarding. 
 Immunisation 
Aldrich and 
Sullivan  39 
To determine pharmacists’ 
attitudes toward immunisations 
and assess possible barriers. 
137/500 pharmacists, 
USA 
Immunisation / 
Survey 
Mixed attitudes to providing immunisation, 
concerns on work environment, organisation 
and time pressure. 
Kamal et al.12 To obtain information about 
willingness to provide 
immunisation services, current 
involvement. 
1266/6000 
pharmacists, USA 
(follow-up on a 2001 
survey) 
Immunisation / 
Survey 
Respondents were willing to administer 
vaccines, very willing to counsel and promote 
immunisation. Main factors perceived as 
problematic were availability of time, 
concerns about legal liability. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Luthin et al.66 To examine pharmacy students’ 
knowledge about, attitudes 
toward, and intention to provide 
pharmacy-based immunization 
services (PBIS). 
  Approximately 80% of students 
felt they had sufficient knowledge/skills to 
provide PBIS upon graduation; mean 
and 58% intended to do so. 
Marcum et al.40 To assess the impact of a 
national immunisation training 
certificate program on the 
perceived knowledge, skills and 
attitudes of pharmacy students 
towards pharmacy-based 
immunisations. 
57 pharmacy 
students enrolled in 
immunisation 
elective, USA 
KSA 
Pre-and post-
training /  
Survey 
Increase in knowledge & skills, high positive 
attitudes (capability, job satisfaction, public 
health benefit) around pharmacist 
immunisation between pre & post training. 
Pace et al.38 To determine community 
pharmacists’ attitudes and 
knowledge on providing 
immunizations including 
perceived barriers to 
immunizing. 
129/350 community 
pharmacists, USA 
Survey The majority of respondents believed 
administering immunizations has advanced or 
significantly advanced the profession. 
Commonly reported barriers included time, 
followed by reimbursement and legal liability 
Valiquette and 
Bédard 37 
To describe the knowledge, 
beliefs and attitudes of 
pharmacists towards 
immunisation and determine 
their perceived barriers to 
pharmacist-led immunisation. 
115/201 community 
pharmacists, Canada 
Immunisation / 
Survey 
52% thought pharmacists should be able to 
prescribe and administer vaccines. 
 Pharmacist prescribing 
Dawoud et al.2 To investigate pharmacist 
supplementary prescribers’ 
views and experiences. 
16 pharmacist 
prescribers, UK 
Supplementary 
prescribing / Semi-
structured 
Positive attitude towards supplementary 
prescribing, beliefs it improves patient care 
and provided a step forward in career. 
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interviews 
George et al.51 To investigate community 
pharmacists’ awareness, views 
and attitudes relating to 
independent prescribing. 
217/500 
community 
pharmacists, 
Scotland 
Prescribing /  
Survey 
Positive attitude towards independent 
prescribing by pharmacists, perceiving 
benefits to patients, indicating intention to 
become an independent prescriber. 
Hobson and 
Sewell 53 
To provide data on the views 
of chief pharmacists and 
primary care trust pharmacists 
on the risks and concerns 
surrounding supplementary 
prescribing. 
280/415 Chief & 
PCT pharmacists, 
primary and 
secondary care, 
UK 
Prescribing /  
Survey 
Overall a positive attitude towards 
supplementary prescribing with a belief that 
pharmacists wish to take on role. Concerns 
were raised over the training model for 
supplementary prescribing, professional 
competence and responsibility once trainees 
qualify. 
Hoti et al.52,59 To compare the attitudes of 
hospital and community 
pharmacists regarding an 
expanded prescribing role. 
1049/2592 hospital 
and community 
pharmacists, 
Australia 
Prescribing /  
Survey 
84% agreed to expanded prescribing role 
(mainly supplementary versus independent), 
regarding it as making better use of 
pharmacists’ skills. 
Hutchison et 
al.54 
To determine reasons for 
adoption of additional 
prescribing authorisation. 
314/500 hospital 
pharmacists, Canada  
Prescribing /  
Survey 
 
Pharmacist with APA generally more positive 
(stronger beliefs on values and relevancy, 
increase efficiency of practice, decrease time 
to contact physicians, stronger confidence in 
ability to follow-up) than those without. 
Lloyd and 
Hughes 57 
To explore context and 
experiences in relation to 
supplementary prescribing. 
47 pharmacists, 
primary & secondary 
care, 35 mentors, 
Northern Ireland 
Prescribing /  
Focus groups, semi-
structured 
interviews 
Pharmacists and mentors perceived SP as 
improving job satisfaction, concerns about 
added responsibility 
McCann et 
al.55 
To capture information on 
pharmacist prescribing. 
100 pharmacist 
prescribers, Northern 
Ireland 
Prescribing /  
Survey 
Positive attitude towards independent and 
supplementary prescribing, perceiving 
increased professional autonomy, status, 
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utilisation of skills 
McIntosh et 
al.56 
To investigate newly registered 
pharmacists’ awareness of 
pharmacist prescribing and 
views on potential future roles 
as prescribers. 
418/1658 newly 
registered 
pharmacists, UK 
Prescribing /  
Survey 
 
86% expressed interest in training as 
independent prescriber. Perception that 
prescribing role would improve patient care, 
enhance professional standing. 
Stewart et al.60 To investigate pharmacists, 
who have not yet applied for a 
supplementary prescribing (SP) 
course, their planned 
participation in training, and 
attitudes towards pharmacist 
SP. 
2371/4300 
pharmacist, 
UK 
Prescribing /  
Survey 
Most determined that practising SP would 
improve the care of their patients and that SP 
would enhance their professional standing. 
Stewart et al.61 To explore the perspectives of 
pharmacist supplementary 
prescribers, their linked 
independent prescribers and 
patients towards pharmacist 
prescribing. 
10 supplementary 
prescribers, Scotland 
Prescribing / 
Interviews 
Perceived benefits to patients (access, quality) 
and increased role satisfaction. Independent 
prescribing 
was considered by all to be the obvious next 
stage in their 
development, which was not supported by 
doctors. 
Tully et al.50 To investigate the views and 
experiences of pharmacists 
before and after they registered 
as supplementary prescribers. 
16 pharmacists, UK Prescribing /  
Semi-structured 
interviews 
Before registration pharmacists were positive 
that their role would change, providing a 
more efficient service in their teams, post 
registration many weren’t able to use their 
skills. 
Warchal et al.58 To explore whether completing 
a prescribing course can 
empower pharmacists in terms 
38 pharmacist 
supplementary 
prescribers, UK 
Prescribing /  
Survey and 
interviews 
Pharmacists felt confident to undertake SP 
and perceived benefits for themselves and 
patients in taking up their new role. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
of their extended roles.  
Weiss et al.3 To evaluate supplementary 
prescribing by pharmacists. 
23 pharmacist 
supplementary 
prescribers, UK 
Prescribing /  
Semi-structured 
interviews 
The pharmacist supplementary prescribers 
embraced the challenges and benefits of 
supplementary prescribing. They perceived 
clear benefits for patient s and themselves. 
 Other services 
Demik et al.64 To determine correlation 
between existing clinical 
pharmacy services within a 
practice-based research 
network and provider attitudes 
and beliefs regarding 
implementing a new pharmacy 
intervention. 
40 Pharmacists and 
321 physicians in 
primary care 
practice, USA  
Implementation of 
hypertension and 
asthma 
intervention/ 
Pharmacy service 
and 
TPB surveys 
Pharmacists either were more accepting and 
willing to initiate a new pharmacy 
intervention, or they believed it would be 
more straightforward to implement a new 
program than did their physician counterparts. 
Pharmacists might be more 
willing to participate directly in patient-care 
than physicians are willing to delegate 
responsibility. 
Dobson et al.62 To determine the extent to 
which community pharmacists 
are prepared to be members of 
the health care team, and to 
assess their support for general 
expansion of clinical 
responsibilities. 
470/1337 
community 
pharmacists, 
Canada 
Expansion of 
clinical 
responsibilities / 
Survey 
Most participants indicated community 
pharmacists should be more involved in 
selecting and monitoring drug therapy, and 
be more responsible for treating minor 
illnesses as part of the primary health care 
team.  
Emmerton et 
al.46 
To evaluate experiences of 
pharmacists participating in a 
Pharmacy Asthma Management 
Service 
32 community 
pharmacists, 
Australia 
Pharmacy Asthma 
Management 
Service (PAMS) / 
Focus groups, semi-
structured 
interviews 
Pharmacists embraced participation in the 
PAMS, positive effects on job satisfaction 
and attitude towards future of the service. 
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Freeman et 
al.63 
To describe stakeholder 
opinions of integrating a 
pharmacist into primary care 
practice 
25 community 
pharmacists, 
Australia 
Clinical pharmacy 
service in primary 
care practice / 
Focus groups, semi-
structured interview 
Pharmacists perceived positive aspects in 
providing clinical services within primary 
care practices (medication review, 
prescribing) and envisaged participation in 
specialty clinics. 
Jorgensen et 
al.65 
To assess the thoughts and 
perceptions of pharmacists on 
patient-centred care and 
expanded roles. 
1003 pharmacists, 
Canada 
Pharmacist clinical 
role extension / 
Survey 
Majority of pharmacists’ perceived urgency 
to change their role and showed positive 
attitude towards role extension with 
perceived benefits for patient health 
outcomes and increased job satisfaction. 
Lowrie et al.43 To explore perspectives of 
pharmacists delivering an 
enhanced, pay for performance 
(P4P) community pharmacy HF 
service. 
10 community 
pharmacists, 
Scotland 
Enhanced, P4P HF 
service / 
Focus group 
Pharmacists confident in service delivery, 
experiencing role satisfaction. 
Mansoor et 
al.42 
To assess community 
pharmacists’ attitudes and 
barriers to adherence support 
and investigate activities in 
supporting patient medication 
adherence in their practice. 
126/500 community 
pharmacists, 
Australia 
Adherence support/ 
Survey 
98 % of pharmacists agreed that it was their 
role to promote patients’ adherence. 
O’Connor et 
al.41 
To investigate community 
pharmacists’ attitudes, beliefs, 
feelings, and knowledge about 
palliative care. 
250/1002 
Community 
pharmacists, 
Australia 
Palliative care / 
Survey 
Pharmacists were generally positive about 
providing services and supports for palliative 
care patients, perceiving benefits to patients 
and carers. 
Puspitasari et 
al.45 
To explore the scope of 
pharmacists’ activities in 
supporting CVD secondary 
21 community 
pharmacists, 
Australia 
CVD prevention 
activities /  
Semi-structured 
Pharmacists thought they have an important 
role to play in supporting clients in CVD 
secondary prevention.  
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prevention. interviews 
Rieck et al.47 To explore physician and CP 
perceptions of the CP’s role in 
Australian primary care and 
how these perceptions may 
influence the quality of 
physician/CP CDM 
programmes. 
22 community 
pharmacists, 22 
General 
Practitioners, 
Australia 
Chronic disease 
management /  
Semi-structured 
interviews 
Pharmacists frustrated at trying to move away 
from a business model to a healthcare 
professional service orientated model. 
Schweizer and 
Hughes 48 
To explore the views of 
community pharmacists as to 
their present and potential role 
in providing care to the 
residents of nursing and 
residential homes. 
254/508 community 
pharmacists, 
Northern Ireland. 
Pharmaceutical 
service / Survey 
Pharmacists supported extending their role in 
care homes, e.g. assessing residents’ 
medication needs and providing advice to 
staff. 
Um et al.49 To explore pharmacists’ 
opinions about the provision of 
weight management services. 
 20 Community 
pharmacists, 
Australia 
Obesity 
management / 
Semi-structured 
interviews 
Pharmacists are motivated and willing to 
participate in accredited evidence-based 
weight management programs. 
Wells et al.44 To explore community 
pharmacist and superintendent 
pharmacist views and 
experiences of adherence 
support service. 
15 community 
pharmacists, UK 
Adherence support/ 
Focus groups 
Participants were enthusiastic about the 
potential of an adherence support service to 
benefit patients and the pharmacy profession. 
 834 
 835 
 836 
  837 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Appendix 3. Overview of studies included in review reporting on pharmacists’ attributes  838 
Author(s) / 
year 
Objectives Participants / 
Location 
Instrument Main findings of the study 
Kittisopee 67 To investigate the effect of five 
factors of personality on 
behaviour relative to 
pharmaceutical care. 
341/600 
pharmacists, 
USA 
BFI 
TPB survey 
Personality traits influenced behavioural intention but 
not actual provision of pharmaceutical care, which 
was predicted by TPB factors. 
Hall et al.68 To characterize the personality 
traits of hospital pharmacists to 
provide insights into potential 
barriers to practice change. 
347/766 
hospital 
pharmacists, 
Canada 
BFI Hospital pharmacists tended toward stronger 
expressions of the traits of extraversion, 
agreeableness, conscientiousness, and openness and 
were emotionally stable. 
Rosenthal et 
al.69 
To investigate possible 
relationships between cultural 
factors, personality traits and 
the uptake of advanced practice 
opportunities.  
945/ 4975  
pharmacists, 
Canada 
Organizational 
Culture Profile 
(OCP)  
BFI 
It would appear pharmacist respondents might be 
more likely to exhibit behaviours in line with the 
traits of agreeableness, conscientiousness, and 
openness. Respondents who scored higher on the BFI 
trait extraversion provided a higher number of 
immunizations but lower numbers of medication 
reviews. 
Rosenthal et 
al.70 
To gain descriptive insight into 
the culture and personality 
traits of pharmacists with 
additional prescribing 
authorisation.  
65/167 
pharmacists 
with APA, 
Canada 
OCP 
BFI 
Interpretation of the BFI findings suggests that the 
majority of innovator and early adopter pharmacist 
respondents may be more likely to exhibit behaviour 
in line extraversion, agreeableness, conscientiousness 
and openness.  
Rosenthal et 
al.71 
To compare results of BFI 
measures of pharmacists’ 
performance in a research trial. 
23 pharmacists 
with APA, 
Canada 
BFI 
Performance 
measures 
Pre-specified hypotheses that personality traits would 
correlate to certain performance measures in the 
practice research trial weren’t supported. 
Rosenthal et 
al.72 
To gain insight into the culture 
of hospital pharmacy and into 
hospital pharmacists’ 
personality traits. 
401/5600 
hospital 
pharmacists, 
Canada 
OCP 
BFI 
A significant association was noted between number 
of years in practice and the BFI trait of 
conscientiousness; time spent performing clinical 
activities and scores of agreeableness and 
conscientiousness. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Van 
Rensburg and 
Rothman 76 
To assess the relationship 
between personality 
characteristics and career 
anchors of pharmacists. 
56/62 
pharmacists, 
South Africa 
MBTI 
NEO-PI-R 
Career 
Orientation 
Inventory 
Pharmacists who measured higher on extraversion 
and lower on neuroticism, agreeableness tend to have 
‘General Management’ as a career anchor. 
Pharmacists who measured higher on extraversion, 
openness to experience and lower on neuroticism 
tend to have ‘Service, Challenge, Entrepreneurial 
Challenge’ as career anchors. 
Larson et 
al.77 
To determine whether the Big 
Five personality factors and 
vocational confidence 
measures were useful in 
discriminating among 
educational majors and career 
aspirations.  
55 pharmacy 
students in a 
sample of 312 
university 
students, 
Taiwan 
NEO-PI-R Pharmacy students scored higher for 
conscientiousness, lower for agreeableness and equal 
for other traits compared to other university students. 
Women were more agreeable than males. 
Smithikrai 78 To examine the predictive 
power of each facet of the five-
factor model of personality on 
job success. 
312 
pharmacists in 
a sample of 
2518 
professionals, 
Thailand 
NEO-FFI-S Conscientiousness was the only construct that 
consistently predicted job success across 
six occupations. 
Cordina et 
al.73 
To explore the relationship 
between personality and career 
paths taken by pharmacists. 
282/829 
pharmacists, 
Malta 
Gordon 
Personal 
Profile-
Inventory 
(GPP-I) 
Most of the types of pharmacists considered scored 
closely to the average categories of the GPPI 
attributes.  Pharmacists that do not possess 
personalities that are conducive to patient-oriented 
practice appear to have chosen to practice in non-
traditional areas where, possibly, they have found a 
good fit with their personality and other factors. 
Cordina et 
al.74 
To determine if the personality 
traits of first-year pharmacy 
students match the traits 
required for patient-centered 
practice. 
63/69 
pharmacy 
students, Malta 
GPP-I Students with strong traits of original thinking, 
followed by personal relations, and vigour were 
attracted to pharmacy. Pharmacy students exhibited a 
predisposition to caring and developing caring, 
collaborative relationships with patients and other 
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 839 
 840 
health care providers. 
Cordina et 
al.75 
To study the personality traits 
of a cohort of students studying 
pharmacy and medicine in their 
first and final year. 
40 pharmacy 
students 
followed from 
1st to 5th year, 
Malta 
GPP-I Baseline scores of 1st year pharmacy students 
increased by the end of the course for responsibility, 
cautiousness, original- thinking and vigour. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Highlights 
• Pharmacists’ attitudes and personal attributes towards novel pharmacy services were investigated. 
• Recent empirical research of varying design was summarised by a scoping review. 
• Pharmacists’ personality traits, attributes and attitudes are not major barriers to practice change.  
• Individual pharmacists need support to implement patient-focused, extended services. 
• An analysis indicates systemic and organisational barriers may need to be addressed. 
 
